Submit Release

EIN Presswire’s Year-End Special is here: Buy 5 press releases & get 3 FREE—limited time! Start saving today.

World Media Directory · RSS · Email Newsletters

There were 1,787 press releases posted in the last 24 hours and 442,636 in the last 365 days.

KYAN Technologies Pte Ltd Press Releases

25 Press Releases

Published on May 9, 2022 - 11:04 GMT

KYAN Therapeutics and Curie Oncology Announce Strategic Collaboration to Provide Personalized Cancer Test in Singapore

KYAN Therapeutics uses small data AI in a proprietary phenotypic drug sensitivity assay to guide patient treatment for cancer patients with high and unmet needs SINGAPORE, May 9, 2022 /⁨EINPresswire.com⁩/ -- KYAN Therapeutics teams up with Curie Oncology …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on April 28, 2022 - 06:20 GMT

KYAN Therapeutics and Aesculape CRO Partner to Offer Drug Development Biopharma Services

SINGAPORE, April 28, 2022 /⁨EINPresswire.com⁩/ -- KYAN Therapeutics, Inc. (KYAN) and Aesculape CRO (Aesculape) announce plans to offer drug development optimization services for Pharmaceutical and Biotech companies. Studies in recent years estimate that …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on November 23, 2021 - 12:10 GMT

KYAN Therapeutics Announces Presentation by Collaborators on Personalized Oncology Platform at 63rd ASH Annual Meeting

Clinical data shows that ex-vivo drug sensitivity platform can help guide clinicians’ treatment of relapsed/refractory cancer patients SINGAPORE, November 23, 2021 /⁨EINPresswire.com⁩/ -- KYAN Therapeutics Inc., a biotech company focused on improved …

Distribution channels: Companies, Conferences & Trade Fairs ...
Published on November 11, 2021 - 10:07 GMT

KYAN Therapeutics Presents Preclinical Data on Novel HDACi Targeting KRAS-mutated Cancers at AACR-KCA Conference

First in class, selective Class II HDAC inhibitor shows combinatorial effect against KRAS mutations in prostate and pancreatic cancer SINGAPORE, November 11, 2021 /⁨EINPresswire.com⁩/ -- KYAN Therapeutics Inc., a frontier biotech company with a novel drug …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on November 8, 2021 - 12:43 GMT

KYAN Therapeutics announces Hugo Saavedra as CEO

SINGAPORE, November 8, 2021 /⁨EINPresswire.com⁩/ -- KYAN Therapeutics Inc. (“KYAN”), a frontier biotech company with a novel drug-dose combination optimization platform, Optim.AI, has appointed Hugo Saavedra as Chief Executive Officer effective on January …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...